Home|Journals|Articles by Year

Directory for Medical Articles

Original Article

NMJ. 2013; 2(1): 31-39

A study on anti hyper lipidemic effect of oral administration of cardamom in wistar albino rats.

Kumar Sai Sailesh* Divya** Mukkadan J.k***.


Currently, a number of synthetic hypolipidemic drugs are available and are effective but the associated side effects such as diarrhea, nausea, myositis and abnormal liver function severely handicap their application. Some patients are resistant to or are intolerant of conventional pharmacotherapy. Therefore, alternative approaches are eagerly needed, and plant-based therapies attract much interest, as they are effective in reducing lipid levels and show minimal or no side effects
To evaluate the anti hyperlipidemic activity of oral administration of cardamom extract.
A total of 18 adult male and female Wistar rats, weighing 150-200g, and 60 days of age were selected for this study and divided into three groups with 6 rats in each group. Control group rats received only Rodent chow& water. Hyperlipedimic group received high fat diet and water. Cardamom group received high fat diet and water + Cardamom extract. Blood samples are collected from caudal vein at the tail tip to estimate total cholesterol, HDL, LDL and VLDL and triglycerides.
Oral administration of Cardamom extract significantly (p < 0.001) reduced total cholesterol, HDL, LDL and VLDL and triglycerides.
From this study, we can conclude that the oral administration of cardamom extract have benefitial effects on blood cholesterol, triglyceride, VLDL, HDL and LDL levels. However further pharmacological and biochemical investigations will clearly elucidate the mechanism of action and helpful in projecting these plant extracts as a therapeutic target in diabetes research.

Key words: Anti hyper lipidemic effect, cardamom extract.

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

Review(er)s Central
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.